Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonKRd Regimen in Newly Diagnosed Multiple Myeloma With t(11;14)
NCT07709884Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of sonrotoclax in multiple myeloma (MM), sponsored by First Affiliated Hospital of Soochow University. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
sonrotoclax
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT07709884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07709884.